Income disparities in needle biopsy patients prior to breast cancer surgery across physician peer groups

Brigid K. Killelea, Jeph Herrin, Pamela R. Soulos, Craig E. Pollack, Howard P. Forman, James Yu, Xiao Xu, Sara Tannenbaum, Shi Yi Wang, Cary P. Gross

Research output: Contribution to journalArticle

Abstract

Objective: Evaluate income disparities in receipt of needle biopsy among Medicare beneficiaries and describe the magnitude of this variation across physician peer groups. Methods: The Surveillance, Epidemiology and End Results (SEER)-Medicare database was queried from 2007–2009. Physician peer groups were constructed. The magnitude of income disparities and the patient-level and physician peer group-level effects were assessed. Results: Among 9770 patients, 65.4% received needle biopsy. Patients with low income (median area-level household income < $33K) were less likely to receive needle biopsy (58.5%) compared to patients with high income (≥ $50K) (68.6%; adjusted odds ratio 0.77; 95% confidence interval (CI) 0.65–0.91). Needle biopsy varied substantially across physician peer groups (interquartile range 43.4–81.9%). The magnitude of the disparity ranged from an odds ratio (OR) of 0.50 (95% CI 0.23–1.07) for low vs. high income patients to 1.27 (95% CI 0.60–2.68). The effect of being treated by a physician peer group that treated mostly low-income patients on receipt of needle biopsy was nearly three times the effect of being a low-income patient. Conclusions: Needle biopsy continues to be underused and disparities by income exist. The magnitude of this disparity varies substantially across physician peer groups, suggesting that further work is needed to improve quality and reduce inequities.

Original languageEnglish (US)
JournalBreast Cancer
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Peer Group
Needle Biopsy
Breast Neoplasms
Physicians
Confidence Intervals
Medicare
Odds Ratio
Epidemiology
Databases

Keywords

  • Breast cancer
  • Breast cancer diagnosis
  • Breast cancer treatment
  • Breast surgery
  • Needle biopsy
  • Quality

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Pharmacology (medical)

Cite this

Income disparities in needle biopsy patients prior to breast cancer surgery across physician peer groups. / Killelea, Brigid K.; Herrin, Jeph; Soulos, Pamela R.; Pollack, Craig E.; Forman, Howard P.; Yu, James; Xu, Xiao; Tannenbaum, Sara; Wang, Shi Yi; Gross, Cary P.

In: Breast Cancer, 01.01.2019.

Research output: Contribution to journalArticle

Killelea, Brigid K. ; Herrin, Jeph ; Soulos, Pamela R. ; Pollack, Craig E. ; Forman, Howard P. ; Yu, James ; Xu, Xiao ; Tannenbaum, Sara ; Wang, Shi Yi ; Gross, Cary P. / Income disparities in needle biopsy patients prior to breast cancer surgery across physician peer groups. In: Breast Cancer. 2019.
@article{65f55a01a34b43b787fcf51908400d10,
title = "Income disparities in needle biopsy patients prior to breast cancer surgery across physician peer groups",
abstract = "Objective: Evaluate income disparities in receipt of needle biopsy among Medicare beneficiaries and describe the magnitude of this variation across physician peer groups. Methods: The Surveillance, Epidemiology and End Results (SEER)-Medicare database was queried from 2007–2009. Physician peer groups were constructed. The magnitude of income disparities and the patient-level and physician peer group-level effects were assessed. Results: Among 9770 patients, 65.4{\%} received needle biopsy. Patients with low income (median area-level household income < $33K) were less likely to receive needle biopsy (58.5{\%}) compared to patients with high income (≥ $50K) (68.6{\%}; adjusted odds ratio 0.77; 95{\%} confidence interval (CI) 0.65–0.91). Needle biopsy varied substantially across physician peer groups (interquartile range 43.4–81.9{\%}). The magnitude of the disparity ranged from an odds ratio (OR) of 0.50 (95{\%} CI 0.23–1.07) for low vs. high income patients to 1.27 (95{\%} CI 0.60–2.68). The effect of being treated by a physician peer group that treated mostly low-income patients on receipt of needle biopsy was nearly three times the effect of being a low-income patient. Conclusions: Needle biopsy continues to be underused and disparities by income exist. The magnitude of this disparity varies substantially across physician peer groups, suggesting that further work is needed to improve quality and reduce inequities.",
keywords = "Breast cancer, Breast cancer diagnosis, Breast cancer treatment, Breast surgery, Needle biopsy, Quality",
author = "Killelea, {Brigid K.} and Jeph Herrin and Soulos, {Pamela R.} and Pollack, {Craig E.} and Forman, {Howard P.} and James Yu and Xiao Xu and Sara Tannenbaum and Wang, {Shi Yi} and Gross, {Cary P.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s12282-019-01028-4",
language = "English (US)",
journal = "Breast Cancer",
issn = "1340-6868",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Income disparities in needle biopsy patients prior to breast cancer surgery across physician peer groups

AU - Killelea, Brigid K.

AU - Herrin, Jeph

AU - Soulos, Pamela R.

AU - Pollack, Craig E.

AU - Forman, Howard P.

AU - Yu, James

AU - Xu, Xiao

AU - Tannenbaum, Sara

AU - Wang, Shi Yi

AU - Gross, Cary P.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: Evaluate income disparities in receipt of needle biopsy among Medicare beneficiaries and describe the magnitude of this variation across physician peer groups. Methods: The Surveillance, Epidemiology and End Results (SEER)-Medicare database was queried from 2007–2009. Physician peer groups were constructed. The magnitude of income disparities and the patient-level and physician peer group-level effects were assessed. Results: Among 9770 patients, 65.4% received needle biopsy. Patients with low income (median area-level household income < $33K) were less likely to receive needle biopsy (58.5%) compared to patients with high income (≥ $50K) (68.6%; adjusted odds ratio 0.77; 95% confidence interval (CI) 0.65–0.91). Needle biopsy varied substantially across physician peer groups (interquartile range 43.4–81.9%). The magnitude of the disparity ranged from an odds ratio (OR) of 0.50 (95% CI 0.23–1.07) for low vs. high income patients to 1.27 (95% CI 0.60–2.68). The effect of being treated by a physician peer group that treated mostly low-income patients on receipt of needle biopsy was nearly three times the effect of being a low-income patient. Conclusions: Needle biopsy continues to be underused and disparities by income exist. The magnitude of this disparity varies substantially across physician peer groups, suggesting that further work is needed to improve quality and reduce inequities.

AB - Objective: Evaluate income disparities in receipt of needle biopsy among Medicare beneficiaries and describe the magnitude of this variation across physician peer groups. Methods: The Surveillance, Epidemiology and End Results (SEER)-Medicare database was queried from 2007–2009. Physician peer groups were constructed. The magnitude of income disparities and the patient-level and physician peer group-level effects were assessed. Results: Among 9770 patients, 65.4% received needle biopsy. Patients with low income (median area-level household income < $33K) were less likely to receive needle biopsy (58.5%) compared to patients with high income (≥ $50K) (68.6%; adjusted odds ratio 0.77; 95% confidence interval (CI) 0.65–0.91). Needle biopsy varied substantially across physician peer groups (interquartile range 43.4–81.9%). The magnitude of the disparity ranged from an odds ratio (OR) of 0.50 (95% CI 0.23–1.07) for low vs. high income patients to 1.27 (95% CI 0.60–2.68). The effect of being treated by a physician peer group that treated mostly low-income patients on receipt of needle biopsy was nearly three times the effect of being a low-income patient. Conclusions: Needle biopsy continues to be underused and disparities by income exist. The magnitude of this disparity varies substantially across physician peer groups, suggesting that further work is needed to improve quality and reduce inequities.

KW - Breast cancer

KW - Breast cancer diagnosis

KW - Breast cancer treatment

KW - Breast surgery

KW - Needle biopsy

KW - Quality

UR - http://www.scopus.com/inward/record.url?scp=85075942113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075942113&partnerID=8YFLogxK

U2 - 10.1007/s12282-019-01028-4

DO - 10.1007/s12282-019-01028-4

M3 - Article

C2 - 31792804

AN - SCOPUS:85075942113

JO - Breast Cancer

JF - Breast Cancer

SN - 1340-6868

ER -